Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Recruiting · NCT05188170 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Niclosamide in Pediatric Patients With Relapsed and Refractory AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-12 | NCT05188170 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CURE Childhood Cancer, Inc. | 1 |
| Pediatric Cancer Research Foundation (PCRF) | 1 |
| Stanford University | 620 |
| The Leukemia and Lymphoma Society | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford University | Palo Alto | United States | 51 |